氨氯地平

  • 网络Amlodipine;amlodipine besylate;Norvasc
氨氯地平氨氯地平
  1. 厄贝沙坦组与氨氯地平组治疗前房内传导间期无统计学差异,但均与对照组房内传导间期有明显统计学差异(P0.01)。

    Irbesartan and amlodipine groups before treatment have no statistically difference in the atrial conduction interval , but they all have statistically difference with the control group .

  2. 依那普利+氨氯地平组和依那普利+钠催离组降压达标率分别为60%和50%。

    The rate of achieve goal BP were 60 % vs 50 % in enalapril combine amlodipine group and enalapril combine natrilix group .

  3. 氨氯地平对高血压患者左心室肥厚及高敏C反应蛋白的影响

    Amlodipine to left ventricular hypertrophy and high-sensitivity C-reactive protein in patients with hypertension

  4. 氨氯地平片剂的HPLC测定

    Determination of amlodipine in tablets by HPLC

  5. HPLC法测定人血清中氨氯地平浓度

    Determination of amlodipine in serum by HPLC

  6. 不良反应发生率氨氯地平组15%显著低于尼群地平组的21%(P<0.01),且反应轻微,无1例终止治疗。

    Adverse effects of amlodipine group were fewer than those of nitrendipine group ( 15 % vs 21 % , P < 0.01 ) .

  7. 高血压组分为氨氯地平组(A组)59例,厄贝沙坦组(B组)60例。

    Hypertension group is divided into amlodipine group ( A group ) with 59 cases , irbesartan group ( B group ) with 60 cases .

  8. 目的研究氨氯地平舒张周围血管的作用是否与激活一氧化氮合酶(NOS)有关。

    Objective To determine whether vasorelaxation induced by amlodipine depend on eNOS activation .

  9. RP-HPLC测定苯磺酸氨氯地平片中的有关物质

    Determination of related substances in Amlodipine Besylate by RP-HPLC

  10. 氨氯地平对SHR肾小球系膜细胞的保护作用

    Protective Effect of Amlodipine on SHR Glomerular Mesangial cell

  11. 氯沙坦及氨氯地平对肾移植患者24h尿蛋白及血、尿转化生长因子β1的影响

    Effect of Losartan and Amlodipine on serum and urine transforming growth factor-beta 1 in kidney transplantation recipients

  12. 氨氯地平对人乳腺癌细胞MCF-7细胞的抑制作用及机制研究

    Study on inhibitory effects and mechanism of amlodipine on human breast carcinoma cell line MCF-7

  13. 氨氯地平对CHF大鼠血浆ET-1和BNP表达的影响

    Effect of Amlodipine on Expression of ET-1 and BNP in Plasma of Rats with Congestive Heart Failure

  14. 氨氯地平对2型糖尿病大鼠肾脏细胞凋亡及bax和bcl-2表达的影响

    Effects of calcium antagonist on apoptosis and expression of bcl-2 , bax in renal tissues of rat with type 2 experimental diabetes

  15. 实验中建立了用CE/FA测定以那格列奈为代表的酸性药物以及氨氯地平异构体与蛋白的结合参数。

    CE / FA is used to to determine the binding parameters of the acidic drug nateglinide and amlodipine enantiomers to protein .

  16. 咪达普利和氨氯地平对高血压病左室肥厚患者QT离散度及室性心律失常影响的研究

    Effect of Imidapril on QT interval dispersion and ventricular arrhythmia in patients with left ventricular hypertrophy caused by hypertension

  17. 氨氯地平治疗高血压对左室肥厚及血清hsCRP和BNP的影响

    The influence of amlodipine on serum level of hsCRP and BNP in hypertension

  18. 缬沙坦单药与缬沙坦联合氨氯地平对高血压患者血压及ET-1的影响

    Effects of Valsartan and Valsartan Combine with Amlodipine on the Blood Pressure and ET-1 in Patients with Essential Hypertension

  19. 结论:氨氯地平能够明显降低轻中度高血压病患者24h血压,并能使其左室肥厚明显消退。

    Conclusion : Amlodipine can significantly lower blood pressure and make left ventricular hypertrophy regression in mild to moderate hypertension .

  20. 结论(1)氨氯地平能抑制SHR系膜细胞的肥大与增殖。

    Conclusions ( 1 ) The hypertrophy and proliferation of SHR mesangial cell could be inhibited by amlodipine .

  21. 方法:检测正常和甘油所致ARF大鼠不同时间血浆CGRP、ET和血清NO水平的变化,并观察应用氨氯地平对肾脏功能及血浆CGRP、ET和血清NO的影响。

    Methods : Plasma CGRP , ET and serum NO levels of glycerol-induced ARF rats with or without treatment with amlodipine were measured .

  22. 氨氯地平组治疗前后房内传导间期变化无统计学差异(P0.05)。结论(1)高血压病患者心房内传导间期存在异常。

    Amlodipine group before and after treatment , there were no statistically difference . Conclusion : 1 . abnormalities are existed in hypertensive patients atrial conduction interval . 2 .

  23. 氨氯地平加替米沙坦对轻、中度高血压的疗效及与AVP和NO的关系

    Effects of amlodipine plus telmisartan on mild to moderate hypertension and their relationship to plasma AVP and NO

  24. 最后,还有提醒MD要继续服用氨氯地平,它也是原先复方制剂中的一种成分。

    Finally , MD should be reminded that she will still receive her amlodipine , however , not as part of a combination tablet .

  25. 目的建立测定人体血浆苯磺酸左旋氨氯地平浓度的反相高效液相色谱测定法(RP-HPLC)。

    Objective To set up an RP-HPLC method for the determination of the concentration of ( S ) - amlodipine benzenesulfonate in human blood plasma .

  26. MMP-2、MMP-3、TIMP-1及氯沙坦与氨氯地平在老年前期自发性高血压大鼠肾硬化中的作用及其机理探讨

    MMP-2 , MMP-3 and TIMP-1 in glomerular sclerosis of SHR and mechanism of delaying glomerular sclerosis by treatment with losartan and amlodipine

  27. 目的探讨钙拮抗剂氨氯地平(amlodipine)与转换酶抑制剂依那普利(enalapril)抗高血压治疗时对肾脏的保护作用。

    Objective To study the protective effect of antihypertensive therapy with calcium channel antagonist ( CCA ) amlodipine and ACEI enalapril .

  28. 目的:探讨氨氯地平对原发性高血压(EH)患者心肾的作用及其与细胞内胞浆游离钙([Ca2+]i)的关系。

    Objective : To investigate the relationship between intracellular free calcium concentration and the effect of amlodipine therapy on heart and renal functions in essential hypertensive patients .

  29. 2型糖尿病合并高血压患者24h动态血压变化分析缬沙坦联合氨氯地平治疗糖尿病合并高血压病效果观察

    Analysis of 24-Hour Ambulatory Blood Pressure in Type 2 Diabetes Accompanied with Hypertension Clinical Effect and Investigation of Valsartan and Amlodipine Administration in Diabetic Patients with Hypertension

  30. 结论:氨氯地平治疗EH可达到平稳降压、逆转左心室重构和肾功能损害的疗效,[Ca2+]i的降低可能参与其改善心肾功能作用。

    Conclusion : The mechanisms of antihypertensive effect and improvement of heart and renal function by amlodipine therapy may be associated with the normalization of intracellular calcium metabolism .